• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 521245 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413940670 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413940670 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Investors look to Lighten Up on Shares of Pacific Biosciences of California , Shares Down 6.8% (PACB)

Published on Fri, 06/21/2013 - 12:28
By Adrienne Chilton

Pacific Biosciences of California (NASDAQ:PACB) is one of today's worst performing low-priced stocks, down 6.8% to $2.47 on 1.1x average daily volume. Thus far today, Pacific Biosciences of California has traded 477,000 shares, vs. average volume of 453,000 shares per day. The stock has underperformed the Dow (-6.8% to the Dow's 0.3%) and underperformed the S&P 500 (-6.8% to the S&P's 0.2%) during today's trading.

Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The Company's system enables real-time analysis of biomolecules with single molecule resolution.

In the past 52 weeks, Pacific Biosciences of California share prices have been bracketed by a low of $1.06 and a high of $3.25 and are now at $2.47, 133% above that low price. The 200-day and 50-day moving averages have moved 0.87% higher and 1.56% higher over the past week, respectively.

Potential upside of 6.6% exists for Pacific Biosciences of California , based on a current level of $2.47 and analysts' average consensus price target of $2.63. The stock should hit resistance at its 50-day moving average (MA) of $2.52, as well as support at its 200-day MA of $2.09.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Rentrak Looks to Continue to Trade Above...

Rentrak (NASDAQ:RENT) traded at a new 52-week high today of $76.50. So far today appro ...

Watch for Continued Gains in Shares of O...

Shares of O'Reilly Automotive (NASDAQ:ORLY) traded today at $158.93, breaking its 52-we ...

Netease.com: The Winning Streak Continue...

Netease.com (NASDAQ:NTES) traded at a new 52-week high today of $94.97. This new high ...

Watch for Continued Gains in Shares of N...

Shares of Nautilus (NYSE:NLS) traded at a new 52-week high today of $13.41. This new h ...

Watch for Continued Gains in Shares of M...

Micron Technology (NASDAQ:MU) traded at a new 52-week high today of $30.93. This new h ...

Monster Worldwide Looks to Continue to T...

Monster Worldwide (NASDAQ:MNST) traded today at a new 52-week high of $99.05. So far t ...

Watch for Continued Gains in Shares of L...

Landstar System (NASDAQ:LSTR) traded at a new 52-week high today of $74.02. So far tod ...

Shares of Kilroy Realty Rise to a New 52...

Shares of Kilroy Realty (NYSE:KRC) traded at a new 52-week high today of $64.36. This ...